MetLife Investment Management’s ASP Isotopes ASPI Stock Holding History
Bought
Maintained
Sold
Other funds holding ASPI
ECA
VCM
RIM
ETC
AIC
MetLife Investment Management's ASPI Position: Q1 2026 in Review
MetLife Investment Management increased its ASP Isotopes (ASPI) stake by 21% in Q1 2026, buying an estimated $64.8K and bringing the position to 63,587 shares worth $281K. The position accounts for ﹤0.01% of the portfolio, ranked #2043.
MetLife Investment Management first reported a position in ASPI in Q3 2024 and has held it in 7 quarters since. The position peaked at $440K in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.
- MetLife Investment Management held 63,587 shares of ASP Isotopes worth $281K as of Q1 2026.
- MetLife Investment Management bought 10,954 ASP Isotopes shares in Q1 2026, an estimated $64.8K.
- ASP Isotopes made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #2043 holding.
- MetLife Investment Management first reported a position in ASP Isotopes in Q3 2024 and has held it in 7 quarters since.
- MetLife Investment Management's ASP Isotopes position peaked at $440K in Q3 2025.
- 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.